Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$821.4K
20.89K shares
What this filing means
KARLIN DANIEL plans to sell 20.89K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $821.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2026ACC: 0001950047-26-009814
Officer· Chief Medical Officer
Since Jan 2022
20.89K
Shares to sell
$821.4K
Approx. market value
10.85K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
9/25/2026
10.85KTotal acquired10.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 10.85K | — |
| Total | 10.85K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.04K
Market value
$422.8K
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.85K
Market value
$398.6K
9/25/2026
Total
Units
20.89K
Value
$821.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 10.04K | $422.8K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2026 | 10.85K | $398.6K | NASDAQ | Planned |
| Total | 20.89K | $821.4K | ||